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Abstract NuMA is a protein involved in maintenance of nuclear structure and in the assembly of the mitotic spindle. Expression of amino-terminal 
deletion mutants results in a phenotype identical to that caused by a temperature-sensitive def ct of RCCl (regulator of chromosome condensation). 
Here we describe the isolation of NuMA protein from HeLa cells under mild conditions as a prerequisite ostudy its interactions with elements of 
the RCCl-Ran regulatory pathway. In an overlay assay, NuMA did not bind Ran.&“P]GTP. Thus it is clearly different from Ran.GTP binding 
proteins of similar M,. 
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1. Introduction initial experiments to study the putative interaction with the 
RCCl-Ran signal pathway. 
NuMA is a 236 kDa protein found dispersed throughout the 
nucleus of mammalian cells during interphase and, during mi- 
tosis, associated with the pericentrosomal regions of the mitotic 
spindle. It had also been designated centrophilin, SPN [2], SPN 
[3], SP-H antigen [4], or lFl/lHl antigen [5]. Injection of mon- 
oclonal antibodies to NuMA before anaphase inhibits mitosis 
[3,6,7] and leads to formation of micronuclei [8]. NuMA ap- 
pears to be involved in the nucleation and organization of 
mitotic, but not interphase, microtubules [9], and in spindle 
pole function [7], possibly by acting as a mitotic microtubule- 
associated protein [lO,l I]. It has been found to co-precipitate 
in immune complexes with antibodies to small nuclear ribonu- 
cleoproteins, and associates with in vitro-reconstituted splicing 
complexes [121. 
2. Materials and methods 
2.1. Cell culture and synchronization of HeLa cells in suspension 
HeLa S3 cells were grown in Joklik’s modified MEM supplemented 
with 5% newborn calf serum (Biochrom, Berlin) to a density of 4 x lo5 
cells/ml. For synchronization in mitosis, nocodazole was added to a 
Snal concentration of 80 ng/ml. The cells were incubated for 16 h, 
collected by centrifugation at 800 x g, washed twice in PBS and once 
in PBS containing protease inhibitors [22], and processed immediately 
without freezing. 
2.2. Purification of NuMA protein from HeLa ceil lysates 
Its primary structure, translated from the cDNA sequence, 
indicates a large central coiled-coil region, flanked by globular 
head and tail domains [5,9,11,13]. Alternative splicing of the 
mRNA transcript leads to proteins which differ at their car- 
boxyl-terminal region [11,13], that carries signals for nuclear 
localization and association with the mitotic spindle [14]. Ec- 
topic expression of amino-terminally deleted NuMA constructs 
results in failure to undergo cytokinesis and the appearance of 
multiple micronuclei [15]. Morphologically, this phenotype is 
very similar to that resulting from a temperature-sensitive mu- 
tation in RCCl, the regulator of chromosome condensation 
[ 161. Over-expression of wild-type NuMA results in partial sup- 
pression of the terminal phenotype of temperature-sensitive 
RCCl [lS]. 
Therefore, NuMA may be a target of the RCCl-Ran path- 
way, which has been implicated in nuclear import of proteins 
[ 17,181, pre-mRNA processing and export [ 191, regulation of 
the initiation of S phase and chromosomal DNA synthesis [20], 
maintenance of nuclear structure, and the onset of and exit 
from mitosis [16,21]. To date, four components of this pathway 
have been characterized biochemically: RCCl [22], Ran [23], 
RanGAPl [24], and RanBPl [25,26]. Here we report the isola- 
tion of NuMA from HeLa cells under mild conditions and 
40 ml of freshly harvested packed HeLa cells were suspended in 100 
ml of lysis buffer (20 mM bis-Tris propane-HCl, pH 6.9,l mM EDTA, 
1 mM DTT and protease inhibitors), swollen on ice for 30 min, homog- 
enized by 8 strokes in a Dounce homogenizer, and centrifuged at 
70,000 x g for 45 min. In lysates of interphase cells the antigen was 
found in the pellet, whereas in nocodazole-blocked c lls the majority 
was in the supematant (not shown). NuMA from unsynchronized cells 
was solubilized by resuspencling the pellet in lysis buffer containing 400 
mM NaCl to a final volume of 100 ml with 20 strokes in the homoge- 
nizer, followed by centrifugation at 70,000 x g for 30 min. The supema- 
tant was diluted with lysis buffer to a final concentration of 100 mM 
NaCl, filtered through a G4 Buchner funnel and chromatographed on 
DMAE-Fractogel (Merck; 13.5 x 2.5 cm) in 20 mM bis-Tris propane- 
HCI, pH 6.9, 1 mM EDTA, 1 mM DTT with a flow rate of 5 mUmin 
and a gradient of 100 mM to 1 M NaCl. Protease inhibitors were 
re-added to NuMA-positive fractions. To remove residual nucleic 
acids, the sample was incubated with 25 U/ml of benzonase (Merck) for 
2 h at 4°C. It was then gel-filtrated on a S-500 Sephacryl column 
(Pharmacia; 110 x 2.5 cm) in 25 mM Tris, pH 7.2,25 mM NaCl, 1 mM 
DTI and 1 mM EDTA, at a flow rate of 0.7 ml/min. Fractions contain- 
ing NuMA were applied to Lichrospher 4000 TMAE (Merck; 4 x 1 cm), 
and final purification was achieved with a gradient from 30 mM to 250 
mM NaCl at a flow rate of 1 ml/min. Speed was essential during this 
separation to minimize proteolytic degradation, the procedure taking 
about 32 h. All steps were performed at 4’C. 
2.3. Immunoblotting and overlay assay of renatured blots with 
Ran. [y-=P]GTP 
*Corresponding author. Fax: (49) (6221) 423 460. 
Blots were performed as previously described [23]. Immunostaining 
was done with 1: 500 dilutions of human autoimmune serum 2642 to 
NuMA, and with autoantibody aBinity-purified on the 236 kDa band 
as described [22]. For confirmation of the identity, monoclonal antibod- 
ies SPN7 and PON2 to NuMA were utilized (kindly provided by M. 
Osbom, Gettingen). Secondary goat anti-human peroxidase-labeled 
antibodies (Amersham) were detected by incubation with a solution 
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containing 0.5 mg/ml of diaminobenzidine, 0.02% CoCl,, and 1 /A/10 
ml of 30% H,O, in TBS, which was added immediately before use. 
For the overlay assay, 50 pg of soluble HeLa protein fraction [23] per 
lane were separated on a 8% SDS-gel and transferred to nitrocellulose. 
Blotted proteins were denatured with 6 M guanidinium chloride in 50 
mM Tris-HCl, pH 7.6, 1 mM DTT and renatured by dropwise addition 
of TBS (10 mM Tris-HCl, pH 7.6,150 mM NaCl), 5 mM MgCl,, 1 mM 
DTT. After three 1: 10 dilition steps nitrocellulose strips were blocked 
for 30 min with 5% skimmed milk Dowder in TBS-ME*+-DTT. Preincu- 
bation was done for 10 min with 3~ml TBS-Me-D* containing 0.5% 
milk powder and 100 ,uM each of GTP and GDP. After incubating for 
10 min with 2 nM Ran.[y-“P]GTP, the strips were washed ten times 
with TBS-Mg2’-DTT, dried and autoradiographed. 
3. Results 
3.1. Distribution of NuMA antigen in HeLa cells in interphase 
and mitosis 
From our collection of some 5000 human autoimmune sera, 
11 sera derived from patients with rheumatoid arthritis, pri- 
mary Sjijgren syndrome, and silicosis, recognized a 236 kDa 
protein band on immunoblots. In indirect immunofluorescence 
studies in HeLa cells the antigen showed a distribution corre- 
sponding to patterns described previously for NuMA [l], cen- 
trophilin [2], SPN [3], and SP-H antigen [ 111. In interphase cells, 
the antigen is diffusely distributed in the nucleus whilst nucleoli 
remain unstained. In early mitotic stages it is enriched in the 
polar regions of the spindle (data not shown). The immunofluo- 
rescence pattern and the identity of the purified 236 kDa pro- 
tein on immunoblots with NuMA were confirmed with mono- 
clonal SPN7 and PON2 antibodies to NuMA, kindly provided 
by Dr. Osborn [3]. 
3.2. PuriJication of NuMA protein from HeLa lysates 
A band of antigen was seen at about 236 kDa on im- 
munoblots of HeLa cell lysates that were stained with human 
autoimmune serum 2642. In most fractions one or two bands 
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of lower molecular weight (about 190 kDa) were also observed, 
even when cells were immediately boiled in electrophoresis 
buffer. These bands could represent isoforms of NuMA derived 
from differential splicing of transcripts [13,14]. Human au- 
toantibody 2642, affinity purified from either band, re-stained 
both bands. PON2 and SPN7 monoclonal antibodies stained 
the 236 kDa band only. In addition, all of our 11 autoimmune 
sera with a NuMA-like distribution pattern also stained the 236 
kDa and the 190 kDa band of NuMA protein on blots (not 
shown). 
In mitotic cells treated with nocodazole (or colchicine, 
vinblastine, taxol) most of the antigen is readily soluble in low 
salt buffers, whereas higher concentrations of sodium chloride 
were required to extract it from the nuclear pellet of untreated, 
unsynchronized cells. This may reflect its association with other 
molecules in the nuclei of interphase cells, because, once ex- 
tracted, the antigen is soluble under low salt conditions. 
NuMA has been isolated previously from antibody affinity 
columns upon denaturation with guanidinium chloride [27], 
and from immunoprecipitates after denaturation by SDS-gel 
electrophoresis [8,27]. As a prerequisite for studying the possi- 
ble association of native NuMA with other proteins, we devel- 
oped a rapid purification scheme applying mild conditions 
more likely to preserve native structure and function (Fig. 1). 
In this procedure, the pellets of HeLa cell lysates were extracted 
with 400 mM NaCl, and the extract was chromatographed on 
DMAE Fractogel (Fig. 1A). 
Upon gel-filtration of these fractions on Sephacryl S-500, 
NuMA from both interphase and mitotic cells eluted with an 
apparent IV, of about 1.5 x 106, suggestive of oligomer forma- 
tion. Fig. 1B shows this for NuMA from unsynchronized cells. 
These fractions were also tested on immunoblots with antisera 
to RCCl and Ran to detect co-enrichment of these proteins. 
The results were negative and are not shown. 
Final purification was achieved on TMAE Lichrospher 
kDa 1 2 
300 ml 400 ml 20 ml 
Fig. 1. Purification of NuMA protein from HeLa cells. (A) Chromatography of NuMA protein from cell lysates on DMAE-Fractogel in 20 mM 
kDa 1 2 
C 
kDa 1 2 9 
z 
0.5 
bi;Tris propane-HCl, pH 6.9.-(B) Gel-filtration on Sephacryl S-500 & ?5 AM Tris-HCi, pH 7.2. The markers indicated by arrows were, from 
left-to-right (M,: thyroglobulin (669,000); ferritin (440,000); /3-amylase (200,000); bovine serum albumin (66,000). (C) Chromatography on Lichro- 
spher TMAE 4000 in 25 mM Tris-HCl, pH 7.2. Insets: 1, blot with Ponceau S after gel-electrophoresis and transfer to nitrocellulose of hatched antigen 
fractions; 2, immunostaining of blotted proteins with human autoimmune serum 2642. 
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(Fig. IC). This resulted in a 199-fold enrichment of the NuMA 
protein (Table l), which still contained traces of antigen with 
higher electrophoretic mobility. We calculated the number of 
NuMA molecules per cell to be close to one million, compared 
to 10 million of Ran and about 400,000 of RCC 1. This protein, 
purified under mild conditions, will be used to study the puta- 
tive interactions with the known elements of the RCCl-Ran 
pathway. 
3.3. Overlay assay with R~~.[Y-~~P]GTP to correlate Nuh4A 
with RanBP2 or other Ran. GTP binding proteins 
Of the elements of the RCCl-Ran pathway so far identified, 
a protein tentatively designated RanBP2 has an apparent mo- 
lecular weight of c 230,000. RanBP2 selectively binds 
Ran.GTP but not Ran.GDP (Bischoff et al., in prep- 
aration). It is therefore considered an effector of the pathway. 
Persistence of its binding to Ran. GTP in the presence of EDTA 
with an excess of unlabeled GTP indicates that it stabilizes GTP 
binding to Ran. Other bands of similar mobility in gel-electro- 
phoresis have been identified by their capacity to bind selec- 
tively to Ran. GTP [26]. On binding to various targets, RanBP2 
bound to Ran.GTP might help to fulfill one of the functions 
which are disturbed by the loss of RCCl in various systems. 
The amino acid sequence of RanBP2 is unknown. Because of 
the similar M, of this protein to that of NuMA and the putative 
involvement of NuMA in the RCCl-Ran pathway discussed 
below, it was suspected that NuMA could be RanBP2 or one 
of the other Ran.GTP binding proteins of high molecular 
weight. We tested this possibility using an overlay assay with 
R~~.[Y-~*P]GTP on renatured blots (Fig. 2). Ran-binding ac- 
tivity of a corresponding mass is present in the crude HeLa 
lysate. However, it is not co-enriched but lost on purification 
of NuMA. Thus, NuMA is clearly different from the Ran- 
binding proteins so far described. 
4. Discussion 
NuMA is essential for the establishment of mitotic spindles 
[7,8] and the re-formation of the nucleus after mitosis [15]. In 
this study we present a rapid purification procedure for NuMA, 
since the purified protein is required for biochemical investiga- 
tion of its function. NuMA isolated from cells which were 
blocked in mitosis by nocodazole was readily soluble in buffers 
1234 
Fig. 2. Overlay assay of blots containing NuMA and RanBP2 with 
Ran .Iv~*P~GTP. Lanes 1 and 3. soluble fraction of lvsate 
of no&da&e arrested mitotic HeLa;‘lanes 2 and 4, purified N;MA; 
lanes 1 and 2, overlay assay with Ran. [y-“PI-GTP after renaturation; 
lanes 3 and 4, immunostaining with human autoimmune serum 2642 
to NuMA. 
Table 1 
Enrichment of NuMA protein 
Fraction Total NuMA Yield Enrich- 
r$in (mg) (8) ment 
m factor 
70,000 x g pellet 1510 7.6 100 
400 mM salt extract 705 3.6 47 1.01 
Fractogel DMAE 650 20 0.47 6.3 4.7 
Sephacryl S-500 2.7 0.26 3.4 19 
Lichrospher TMAE 4000 0.03 0.03 0.4 199 
Values refer to 50 ml of packed HeLa cells (= 2 x 10” cells) as starting 
material. NuMA was quantitated by staining of gels with Coomassie 
blue (not shown) and of immunoblots with human autoimmune serum 
to NuMA. 
of low ionic strength, in contrast to material from unsynchron- 
ized cells. In the purification steps NuMA from both sources 
behaved similarly, except that the final preparation from mi- 
totic material still contained other proteins. Hence the purifica- 
tion from nocodazole-blocked cells is not shown. 
The experiments of Compton and Cleveland [15] reveal the 
possibility of NuMA being involved in cell cycle regulation 
through the RCCl-Ran pathway: expression of N-terminally 
deleted NuMA results in a terminal phenotype with cells that 
fail to undergo cytokinesis and assemble micronuclei. Morpho- 
logically they are very similar to the temperature-sensitive 
RCCl-defective tsBN2 cells, derived from golden hamster 
BHK21 cells [16]. Over-expression of wild-type NuMA in 
tsBN2 cells partially suppresses this phenotype by restoring 
post-mitotic assembly of a single normal-sized nucleus. 
The RCCl gene product was shown to be bound to chroma- 
tin and to exchange guanine nucleotide bound to the Ras- 
related nuclear protein Ran [22]. The RCCl-Ran pathway has 
been implicated in regulating the initiation of DNA synthesis 
[20], activation of the cdc2 kinase and induction of mitotic 
events [17,28,29], in maintenance of nuclear structure [29], 
RNA processing and export [19], and import of proteins into 
the nucleus [ 17,181. 
So far, the targets of this pathway are unknown. They may 
include Ran-binding proteins, which recognize only its acti- 
vated, GTP-bound form [25,26]. NuMA may also be a down- 
stream element, considering the merely partial complementa- 
tion of the RCCl-defective phenotype by over-expression of 
NuMA [15]. Yet neither RCCl, Ran, nor RanBP2 co-purified 
with NuMA, as judged from immunoblots and from an overlay 
assay for proteins that selectively recognize Ran in its GTP- 
bound form. Larger quantities of purified native and recombi- 
nant NuMA will be required to study its putative interference 
with biochemical reactions of the RCCl-Ran pathway. The 
rapid NuMA purification scheme described here should be a 
step towards these goals. 
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